Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials

A Gędek, Z Szular, AZ Antosik, P Mierzejewski… - Journal of Clinical …, 2023 - mdpi.com
The effects of celecoxib on a broad spectrum of mood disorders and on inflammatory
parameters have not yet been comprehensively evaluated. The aim of this study was to …

Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study

A Hajj, R Hachem, R Khoury, S Hallit, B ElJEBBAWI… - BMC cancer, 2021 - Springer
Background Despite the progress in assessment and treatment of breast cancer, being
diagnosed with it or receiving chemotherapy treatment is still conceived as a traumatic …

Crohn's disease and breast cancer: a literature review of the mechanisms and treatment

S Zhou, J Yu - Internal and Emergency Medicine, 2023 - Springer
This is a literature review describes Crohn's disease (CD) concomitant with breast cancer
and summarizes possible common pathogenic mechanisms shared by the two diseases …

Longitudinal trends in illness perception and depression during adjuvant breast cancer endocrine therapy: a prospective observational study

SK Park, YH Min, SB Lee - Healthcare, 2021 - mdpi.com
This study aimed to identify the changes in the illness perceptions and depression of women
with breast cancer, undergoing AET, at three time points (ie, before initiating AET, 3 months …

[HTML][HTML] Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year …

J García-Sánchez, MA Mafla-España, MD Torregrosa… - The Breast, 2022 - Elsevier
First-line treatment in postmenopausal women with estrogen-and/or progesterone-positive
breast cancer consists of aromatase inhibitors (AROi). The ability of AROi to promote or …

Factors influencing depressive symptoms in Chinese female breast cancer patients: a meta-analysis

Q Zhang, G Wu, J Chen, K Fang, Q Liu… - Frontiers in …, 2024 - frontiersin.org
Objective To systematically evaluate and explore the factors influencing depressive
symptoms in female breast cancer patients in China through meta-analysis. Methods …

[HTML][HTML] Psychometric Properties of the Patient Health Questionnaire-9 in Patients With Breast Cancer

H Park, K Kim, E Moon, H Lim, H Suh… - Psychiatry …, 2024 - ncbi.nlm.nih.gov
Objective Due to the high frequency of depressive symptoms associated with breast cancer,
it is crucial to screen for depression in breast cancer patients. While numerous screening …

Evolución del síndrome de fragilidad en pacientes postmenopáusicas con cáncer de mama precoz operado tratadas con inhibidores de aromatasa adyuvante

J García Sánchez - 2024 - roderic.uv.es
El síndrome de fragilidad (SF) es una entidad que causa pérdida de reserva funcional,
vulnerabilidad a eventos adversos de salud. En pacientes con cáncer de mama invasivo …

Povezanost depresivnosti i anksioznosti sa ekspresijom receptora za neurokinine kod žena obolelih od karcinoma dojke

M Ilić - Универзитет у Крагујевцу, 2024 - nardus.mpn.gov.rs
Karcinom dojke (KD) ostaje gorući globalni problem, kako po pitanju incidence tako iu
pogledu mortaliteta. Poslednjih godina ulažu se napori u definisanju novih molekularnih i …

Anemia y síntomas de depresión en pacientes con cáncer de mama temprano en el Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú

S Casavilca - Revista Peruana de Ciencias de la Salud, 2022 - dialnet.unirioja.es
Objetivo. Determinar la relación entre la anemia y los síntomas de depresión en las
pacientes con cáncer de mama en etapa temprana en el Instituto Nacional de …